DR1 and arthritic joint disease: Using this model, we have confirmed that activation of a large number of DR1-restricted autoimmune CD4+ T cells enhances the severity of the arthritis, and this phenomenon is associated with both increased numbers of autoantibodies and enhanced levels of inflammatory cytokines.